Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder
Gouri Mahajan, Eric J. Vallender, Michael R. Garrett, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 82, pp. 177-186
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

How COVID-19 Affects the Brain
Maura Boldrini, Peter Canoll, Robyn S. Klein
JAMA Psychiatry (2021) Vol. 78, Iss. 6, pp. 682-682
Open Access | Times Cited: 375
Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer’s Disease
Thomas Berger, Hyun Ah Lee, Allan H. Young, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 9, pp. 803-818
Closed Access | Times Cited: 160
Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes
Malosree Maitra, Haruka Mitsuhashi, Reza Rahimian, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 65
Curcumin relieves depressive-like behaviors via inhibition of the NLRP3 inflammasome and kynurenine pathway in rats suffering from chronic unpredictable mild stress
Wenyuan Zhang, Yujin Guo, Wenxiu Han, et al.
International Immunopharmacology (2018) Vol. 67, pp. 138-144
Closed Access | Times Cited: 99
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 9-10, pp. 2851-2894
Open Access | Times Cited: 86
Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-γ pathway
Xue Jiang, Saini Yi, Qin Liu, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 55
Long COVID, neuropsychiatric disorders, psychotropics, present and future
Siu Wa Tang, Brian E. Leonard, Daiga M. Helmeste
Acta Neuropsychiatrica (2022) Vol. 34, Iss. 3, pp. 109-126
Open Access | Times Cited: 47
Verbascoside: A neuroprotective phenylethanoid glycosides with anti-depressive properties
Yi Zhao, Sijia Wang, Jin Pan, et al.
Phytomedicine (2023) Vol. 120, pp. 155027-155027
Closed Access | Times Cited: 26
Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants
David Martín‐Hernández, Javier R. Caso, J. Javier Meana, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 69
Stress-induced disturbances along the gut microbiota-immune-brain axis and implications for mental health: Does sex matter?
Marie‐Claude Audet
Frontiers in Neuroendocrinology (2019) Vol. 54, pp. 100772-100772
Closed Access | Times Cited: 67
Childhood Adversity and Current Stress are related to Pro- and Anti-inflammatory Cytokines in Major Depression
Norbert Müller, Daniela Krause, Rike Barth, et al.
Journal of Affective Disorders (2019) Vol. 253, pp. 270-276
Closed Access | Times Cited: 64
Beneficial effects of running exercise on hippocampal microglia and neuroinflammation in chronic unpredictable stress-induced depression model rats
Kai Xiao, Yanmin Luo, Xin Liang, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 49
Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation
Neta Rimmerman, Hodaya Verdiger, Hagar Goldenberg, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 1120-1135
Closed Access | Times Cited: 43
Identification of potential blood biomarkers associated with suicide in major depressive disorder
Firoza Mamdani, Matthieu D Weber, Blynn G. Bunney, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35
Fluoxetine shows neuroprotective effects against LPS-induced neuroinflammation via the Notch signaling pathway
Jing Zhang, Naiwen Zhang, Jianfeng Lei, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109417-109417
Open Access | Times Cited: 31
Gut proinflammatory bacteria is associated with abnormal functional connectivity of hippocampus in unmedicated patients with major depressive disorder
Shu Xiao, Zibin Yang, Hong Yan, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Extracellular matrix abnormalities in the hippocampus of subjects with substance use disorder
Jake Valeri, Charlotte Stiplosek, Sinead M. O’Donovan, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
Dong Yan, Hengwen Chen, Jialiang Gao, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 52
Maternal depression and inflammation during pregnancy
Marius Lahti‐Pulkkinen, Polina Girchenko, Rachel Robinson, et al.
Psychological Medicine (2019) Vol. 50, Iss. 11, pp. 1839-1851
Open Access | Times Cited: 52
Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats
Yunqiang Wan, Jianguo Feng, Mao Li, et al.
Experimental & Molecular Medicine (2018) Vol. 50, Iss. 10, pp. 1-14
Open Access | Times Cited: 51
Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder
Sophia Attwells, Elaine Setiawan, Pablo Rusjan, et al.
Biological Psychiatry (2020) Vol. 88, Iss. 8, pp. 649-656
Closed Access | Times Cited: 49
Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes
Wenbo Xu, Xiaoxiao Yao, Fangyi Zhao, et al.
Neural Plasticity (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 49
MicroRNAs expressed in depression and their associated pathways: A systematic review and a bioinformatics analysis
Camila Perelló Ferrúa, Roberta Giorgi, Laísa Camerini da Rosa, et al.
Journal of Chemical Neuroanatomy (2019) Vol. 100, pp. 101650-101650
Open Access | Times Cited: 45
Targeting the CCL2-CCR2 axis in depressive disorders
Katarzyna Curzytek, Monika Leśkiewicz
Pharmacological Reports (2021) Vol. 73, Iss. 4, pp. 1052-1062
Open Access | Times Cited: 36
Adolescent stress sensitizes the adult neuroimmune transcriptome and leads to sex-specific microglial and behavioral phenotypes
Mandakh Bekhbat, Deepika Mukhara, Mikhail G. Dozmorov, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 5, pp. 949-958
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top